tiprankstipranks
Trending News
More News >
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Income Statement

Compare
639 Followers

Tenax Therapeutics Income Statement

Last quarter (Q4 2025), Tenax Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tenax Therapeutics's net income was $-15.54M. See Tenax Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 56.38M$ 19.49M$ 8.23M$ 11.05M$ 32.73M
Depreciation and Amortization
$ 0.00$ 0.00$ 8.00K$ 113.33K$ 108.98K
EBITDA
$ -56.38M$ -17.58M$ -7.68M$ -10.93M$ -32.36M
Operating Income
$ -56.38M$ -19.49M$ -8.23M$ -11.05M$ -32.73M
Other Income/Expenses
$ 3.79M$ 1.89M$ 523.00K$ 4.75K$ 253.88K
Pretax Income
$ -52.60M$ -17.60M$ -7.71M$ -11.05M$ -32.47M
Net Income
$ -52.60M$ -17.60M$ -7.71M$ -11.05M$ -32.47M
Per Share Metrics
Basic EPS
$ -1.34$ -1.15$ -31.09$ -600.80$ -2.52K
Diluted EPS
$ -1.34$ -1.15$ -31.04$ -600.80$ -2.52K
Weighted Average Shares Outstanding
39.22M 15.27M 248.00K 18.39K 12.86K
Weighted Average Shares Outstanding (Diluted)
39.22M 15.27M 248.45K 18.39K 12.86K
Currency in USD

Tenax Therapeutics Earnings and Revenue History